Monopar Therapeutics Inc.MNPRNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+31.2%
5Y CAGR+28.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+31.2%/yr
vs +22.6%/yr prior
5Y CAGR
+28.2%/yr
Consistent
Acceleration
+8.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $45.82M | +530.6% |
| 2023 | $7.27M | -11.2% |
| 2022 | $8.19M | -59.7% |
| 2021 | $20.30M | +21.3% |
| 2020 | $16.74M | +26.7% |
| 2019 | $13.21M | +91.7% |
| 2018 | $6.89M | -23.3% |
| 2017 | $8.98M | +333.4% |
| 2016 | $2.07M | +3.4% |
| 2015 | $2.01M | - |